Your browser doesn't support javascript.
loading
miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
Zhao, Xiao-Su; Wang, Yi-Nuo; Lv, Meng; Kong, Yuan; Luo, Hong-Xue; Ye, Xiao-Yang; Wu, Qi; Zhao, Tong-Feng; Hu, Yue-Huan; Zhang, Hong-Yu; Huo, Ming-Rui; Wan, Jun; Huang, Xiao-Jun.
Afiliação
  • Zhao XS; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Wang YN; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Lv M; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Kong Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Luo HX; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • Ye XY; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
  • Wu Q; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Zhao TF; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Hu YH; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Zhang HY; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Huo MR; Shenzhen Key Laboratory for Neuronal Structural Biology, Biomedical Research Institute, Shenzhen Peking University - The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.
  • Wan J; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Oncotarget ; 7(30): 48321-48334, 2016 07 26.
Article em En | MEDLINE | ID: mdl-27340781
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / MicroRNAs / Indolamina-Pirrol 2,3,-Dioxigenase / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / MicroRNAs / Indolamina-Pirrol 2,3,-Dioxigenase / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China